OptimizeRx (OPRX) News Today $18.24 +0.29 (+1.62%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$18.31 +0.07 (+0.38%) As of 08:52 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OPRX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period OptimizeRx (NASDAQ:OPRX) CEO Stephen Silvestro Sells 1,620 SharesOctober 8 at 5:21 AM | insidertrades.comOptimizeRx: How It Is Changing Pharma MarketingOctober 7 at 12:08 AM | seekingalpha.comStephen Silvestro Sells 1,620 Shares of OptimizeRx (NASDAQ:OPRX) StockOctober 7 at 7:11 PM | marketbeat.comOptimizeRx Corp. (NASDAQ:OPRX) Receives Average Rating of "Moderate Buy" from BrokeragesOctober 5, 2025 | marketbeat.comInstitutional investors have a lot riding on OptimizeRx Corporation (NASDAQ:OPRX) with 65% ownershipSeptember 23, 2025 | finance.yahoo.comOptimizeRx (NASDAQ:OPRX) Director Patrick Spangler Sells 11,120 SharesSeptember 13, 2025 | marketbeat.comOptimizeRx (NASDAQ:OPRX) Director Sells $194,488.80 in StockSeptember 12, 2025 | insidertrades.comOptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Rating of "Moderate Buy" from AnalystsSeptember 12, 2025 | marketbeat.comOptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Rating of "Moderate Buy" from BrokeragesSeptember 12, 2025 | marketbeat.comOptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth ConferenceSeptember 10, 2025 | globenewswire.comTrexquant Investment LP Buys New Shares in OptimizeRx Corp. $OPRXSeptember 10, 2025 | marketbeat.comOptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare AdvertisingSeptember 9, 2025 | globenewswire.com475,000 Shares in OptimizeRx Corp. $OPRX Acquired by Parkman Healthcare Partners LLCSeptember 8, 2025 | marketbeat.comOptimizeRx Corp. $OPRX Stock Position Reduced by Walleye Capital LLCSeptember 8, 2025 | marketbeat.comNuveen LLC Takes $455,000 Position in OptimizeRx Corp. $OPRXSeptember 7, 2025 | marketbeat.comAWM Investment Company Inc. Buys 40,000 Shares of OptimizeRx Corp. $OPRXSeptember 5, 2025 | marketbeat.comRussell Investments Group Ltd. Has $397,000 Stock Position in OptimizeRx Corp. $OPRXSeptember 2, 2025 | marketbeat.comInvesco Ltd. Buys Shares of 293,554 OptimizeRx Corp. $OPRXSeptember 1, 2025 | marketbeat.comOptimizeRx Corporation (NASDAQ:OPRX) Is Expected To Breakeven In The Near FutureAugust 25, 2025 | finance.yahoo.comWhetstone Capital Advisors LLC Has $13.06 Million Position in OptimizeRx Corp. $OPRXAugust 23, 2025 | marketbeat.comOptimizeRx announces leadership team advancementsAugust 19, 2025 | msn.comOptimizeRx Announces Leadership Changes for Strategic GrowthAugust 19, 2025 | msn.comOptimizeRx Corp. Announces Leadership Changes to Enhance Growth Strategy and ProfitabilityAugust 19, 2025 | quiverquant.comQOptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic GrowthAugust 19, 2025 | globenewswire.comOptimizeRx Corp. (NASDAQ:OPRX) Receives Average Rating of "Moderate Buy" from AnalystsAugust 17, 2025 | marketbeat.comOptimizeRx Earnings Call: Strong Growth and Positive OutlookAugust 13, 2025 | msn.comOptimizeRx Corporation (NASDAQ:OPRX) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | msn.comJMP Securities Raises OptimizeRx (NASDAQ:OPRX) Price Target to $20.00August 12, 2025 | marketbeat.comOptimizeRx Corp. (OPRX) Stock Price Today - WSJAugust 10, 2025 | wsj.comStifel Nicolaus Forecasts Strong Price Appreciation for OptimizeRx (NASDAQ:OPRX) StockAugust 9, 2025 | marketbeat.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: OptimizeRx (OPRX) and Relay Therapeutics (RLAY)August 9, 2025 | theglobeandmail.comOptimizeRx Corporation (OPRX) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comOptimizeRx Corporation: OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 GuidanceAugust 8, 2025 | finanznachrichten.deOptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 GuidanceAugust 7, 2025 | globenewswire.comOptimizeRx Corp. (NASDAQ:OPRX) Shares Bought by Blair William & Co. ILAugust 7, 2025 | marketbeat.comOptimizeRx (OPRX) Expected to Announce Earnings on ThursdayAugust 1, 2025 | marketbeat.comPaynela Appoints Healthcare Technology Veteran William Febbo to Board of DirectorsJuly 30, 2025 | finance.yahoo.comOptimizeRx Corp. (NASDAQ:OPRX) Shares Sold by Perkins Capital Management Inc.July 28, 2025 | marketbeat.comOptimizeRx Corp. (NASDAQ:OPRX) Shares Sold by Royce & Associates LPJuly 26, 2025 | marketbeat.comInsider Stock Buying Reaches US$2.54m On OptimizeRxJuly 23, 2025 | finance.yahoo.comOptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Rating of "Moderate Buy" by AnalystsJuly 22, 2025 | marketbeat.comOptimizeRx: Stock Could Rise As Profitability Is AchievedJuly 18, 2025 | seekingalpha.comOptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ETJuly 17, 2025 | globenewswire.comCalamos Advisors LLC Invests $289,000 in OptimizeRx Corp. (NASDAQ:OPRX)July 8, 2025 | marketbeat.comInvestors in OptimizeRx (NASDAQ:OPRX) have unfortunately lost 55% over the last three yearsJuly 4, 2025 | finance.yahoo.comOptimizeRx Corp. (NASDAQ:OPRX) Position Boosted by Janney Montgomery Scott LLCJune 30, 2025 | marketbeat.comOptimizeRx Corp. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from AnalystsJune 27, 2025 | marketbeat.comOptimizeRx Corporation Appoints CEO Steve Silvestro to Board of DirectorsJune 24, 2025 | globenewswire.comCalculating The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX)June 18, 2025 | finance.yahoo.comSimulmedia & OptimizeRx partner to bring Micro-Neighborhood® targeting to TV & streamingJune 18, 2025 | msn.com Get OptimizeRx News Delivered to You Automatically Sign up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OPRX Media Mentions By Week OPRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPRX News Sentiment▼0.790.66▲Average Computer and Technology News Sentiment OPRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPRX Articles This Week▼53▲OPRX Articles Average Week Get the Latest News and Ratings for OPRX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for OptimizeRx and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Willdan Group News Upbound Group News Aaron's News Criteo News Telus Digital News NeoGenomics News Radware News i3 Verticals News Yext News Pursuit Attractions and Hospitality News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPRX) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptimizeRx Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share OptimizeRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
